, effectively passivating the defective top surface. As a result, a champion efficiency of 20.38%, the highest efficiency reported for inverted IPSCs to date is achieved. Furthermore, the successful fabrication of a p-i-n type monolithic inorganic perovskite/silicon TSCs with an efficiency of 25.31% for the first time is demonstrated. Crucially, the unencapsulated ABA-treated IPSCs shows enhanced photostability, retaining 80.33% of its initial efficiency after 270 h, and thermal stability (maintain 85.98% of its initial efficiency after 300 h at 65 °C). The unencapsulated ABA-treated TSCs also retains 92.59% of its initial efficiency after 200 h under continuous illumination in ambient air.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: